发明授权
US08957019B2 Oligopeptide for treating liver fibrosis and/or treating hepatitis B and/or improving liver function
有权
用于治疗肝纤维化和/或治疗乙型肝炎和/或改善肝功能的寡肽
- 专利标题： Oligopeptide for treating liver fibrosis and/or treating hepatitis B and/or improving liver function
- 专利标题（中）： 用于治疗肝纤维化和/或治疗乙型肝炎和/或改善肝功能的寡肽
-
申请号： US14346087申请日： 2011-11-01
-
公开(公告)号： US08957019B2公开(公告)日： 2015-02-17
- 发明人: Haimin Lei , Qiang Li
- 申请人： Haimin Lei , Qiang Li
- 申请人地址： CN Beijing
- 专利权人： Haimin Lei
- 当前专利权人： Haimin Lei
- 当前专利权人地址： CN Beijing
- 代理机构： Nath, Goldberg & Meyer
- 代理商 Tanya E. Harkins; Joshua B. Goldberg
- 国际申请： PCT/CN2011/081620 WO 20111101
- 国际公布： WO2013/063755 WO 20130510
- 主分类号： A61K39/29
- IPC分类号： A61K39/29 ; A61K35/407 ; A61K38/08 ; C07K7/06 ; C07K14/47 ; A61K38/00
摘要：
Disclosed is an oligopeptide for treating liver fibrosis and/or hepatitis B and/or improving liver function. The oligopeptide is obtained by reflux extraction via water, ethanol precipitation and isolation through a cation exchange resin column and a gelatinous resin column from a turtle shell. Pharmaceutically conventional excipients can be added to the oligopeptide prepared according to the present invention to prepare various dosage forms. The oligopeptide has good efficacy in treating liver fibrosis and improving liver function.
公开/授权文献
信息查询
